title: Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.
abstract: Healthy females, pregnant with a boy, generate immune responses against male-specific minor histocompatibility (HY) antigens. The clinical importance of these responses is evident in stem cell transplantation. Birth of a boy prior to a series of miscarriages reduces the chance of a subsequent live birth. This study explores the putative impact of known HY-presenting HLA alleles on future pregnancy outcome in women with at least three consecutive miscarriages following a birth [secondary recurrent miscarriage (SRM)]. HLA-A, -B, -DRB1, DRB3-5 and DQB1 genotyping was performed in 358 SRM patients and in 203 of their children born prior to the miscarriages. The subsequent live birth in women with boys prior to the miscarriages compared with girls is lower in women with HY-restricting HLA class II alleles [odds ratio (OR): 0.17 (0.1-0.4), P = 0.0001]. One HY-restricting HLA class II allele in women with firstborn boys significantly reduces the chances of a live birth [OR: 0.46 (0.2-0.9), P = 0.02]. Two HY-restricting HLA class II alleles further reduced this chance [OR: 0.21 (0.1-0.7), P = 0.02]. HY-restricting HLA class II did not reduce the chances of a live birth in SRM women with firstborn girls. HY-restricting HLA class II alleles are associated with a decreased chance of a live birth in SRM women with firstborn boys. These findings strongly indicate an aberrant maternal immune reaction against fetal HY-antigens in SRM. The results may shed light on the as-yet unknown immunological causes of SRM and may help understand the successful maternal acceptance of the fetal semi-allograft.
authors.affiliation: The Fertility Clinic, University Hospital Copenhagen, Rigshospitalet, Denmark. henriette.svarre.nielsen@rh.regionh.dk
authors.forename: Henriette Svarre
authors.initials: HS
authors.lastname: Nielsen
authors.forename: Rudi
authors.initials: R
authors.lastname: Steffensen
authors.forename: Kim
authors.initials: K
authors.lastname: Varming
authors.forename: Astrid G S
authors.initials: AG
authors.lastname: Van Halteren
authors.forename: Eric
authors.initials: E
authors.lastname: Spierings
authors.forename: Lars P
authors.initials: LP
authors.lastname: Ryder
authors.forename: Els
authors.initials: E
authors.lastname: Goulmy
authors.forename: Ole Bjarne
authors.initials: OB
authors.lastname: Christiansen
mesh_terms: D000026:Abortion, Habitual / Q000235:genetics* / Q000276:immunology; D005260:Female; D006182:H-Y Antigen / Q000235:genetics* / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000235:genetics* / Q000276:immunology; D054502:Histocompatibility, Maternal-Fetal; D006801:Humans; D050498:Live Birth; D008297:Male; D011247:Pregnancy / Q000276:immunology*; D011256:Pregnancy Outcome; D012727:Sex Characteristics
chemical_list: D006182:H-Y Antigen; D000949:Histocompatibility Antigens Class II